NCT00301652View on ClinicalTrials.gov

MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

April 30, 2004

Study Completion Date

December 31, 2005

Conditions
VasculitisAnti-Neutrophil Cytoplasmic Antibody
Interventions
DRUG

mycophenolate mofetil

MMF,1.0g/d

Trial Locations (1)

210002

Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing

All Listed Sponsors
lead

Nanjing University School of Medicine

OTHER

NCT00301652 - MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis | Biotech Hunter | Biotech Hunter